Comments
Dr Reddy’s Laboratories Ltd has launched an over-the-counter (OTC) store-brand equivalent of Mucinex D Extended Release Tablets in two strengths.
There are Guaifenesin 600 mg and Pseudoephedrine HCl 60 mg, and Guaifenesin 1200 mg and Pseudoephedrine HCl 120 mg in the United States market, as approved by the U.S. Food and Drug Administration (USFDA).
Dr. Reddy’s OTC Guaifenesin and Pseudoephedrine HCl is used to help loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive; temporarily relieve nasal congestion due to common cold, hay fever, and upper respiratory allergies; temporarily restore freer breathing through the nose; promote nasal and/or sinus drainage; and temporarily relieve sinus congestion and pressure.
"These launches illustrate our continued commitment to the OTC business and our growing portfolio in the cough, cold and allergy category,” Milan Kalawadia, Senior Vice President and Head of US OTC and Specialty Divisions, Dr. Reddy’s Laboratories said in a release.
The Mucinex D brand and store brands had combined U.S. sales of approximately $71 million MAT for the most recent twelve months ending in May 2019 according to IRI*. Mucinex is a trademark of RB Health (US) LLC.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.